01 4DORZOLAMIDE (DORZOLAMIDE HYDROCHLORIDE)
02 15METHYLPHENIDATE HYDROCHLORIDE
03 4TIMOLOL (TIMOLOL MALEATE)
01 7CAPSULE (CONTROLLED RELEASE)
02 8CAPSULE (EXTENDED RELEASE)
03 7SOLUTION
04 1SOLUTION (EXTENDED RELEASE)
01 20.5%
02 1100MG
03 110MG
04 115MG
05 12%
06 12%/W/V
07 120MG
08 220MG/ML
09 125MG
10 130MG
11 135MG
12 140MG
13 145MG
14 150MG
15 155MG
16 25MG/ML
17 160MG
18 170MG
19 180MG
20 185MG
01 8BIPHENTIN
02 2COSOPT
03 2COSOPT PRESERVATIVE-FREE
04 7FOQUEST
05 1TIMOPTIC
06 1TIMOPTIC-XE
07 1TRUSOPT
08 1TRUSOPT PRESERVATIVE-FREE
Regulatory Info : Prescription
Registration Country : Canada
DORZOLAMIDE (DORZOLAMIDE HYDROCHLORIDE)
Dosage Form : SOLUTION
Dosage Strength : 2%
Packaging : 5ML
Brand Name : TRUSOPT
Approval Date :
Application Number : 2216205
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
DORZOLAMIDE (DORZOLAMIDE HYDROCHLORIDE)
Dosage Form : SOLUTION
Dosage Strength : 20MG/ML
Packaging : 10ML
Brand Name : COSOPT
Approval Date :
Application Number : 2240113
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
DORZOLAMIDE (DORZOLAMIDE HYDROCHLORIDE)
Dosage Form : SOLUTION
Dosage Strength : 20MG/ML
Packaging : 60X0.2ML
Brand Name : COSOPT PRESERVATIVE-FREE
Approval Date :
Application Number : 2258692
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
DORZOLAMIDE (DORZOLAMIDE HYDROCHLORIDE)
Dosage Form : SOLUTION
Dosage Strength : 2%/W/V
Packaging : 0.2ML
Brand Name : TRUSOPT PRESERVATIVE-FREE
Approval Date :
Application Number : 2269090
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Schedule G (CDSA III)
Registration Country : Canada
Dosage Form : CAPSULE (CONTROLLED RELEASE)
Dosage Strength : 35MG
Packaging : 60
Brand Name : FOQUEST
Approval Date :
Application Number : 2470306
Regulatory Info : Schedule G (CDSA III)
Registration Country : Canada
Regulatory Info : Schedule G (CDSA III)
Registration Country : Canada
Dosage Form : CAPSULE (CONTROLLED RELEASE)
Dosage Strength : 45MG
Packaging : 60
Brand Name : FOQUEST
Approval Date :
Application Number : 2470314
Regulatory Info : Schedule G (CDSA III)
Registration Country : Canada
Regulatory Info : Schedule G (CDSA III)
Registration Country : Canada
Dosage Form : CAPSULE (CONTROLLED RELEASE)
Dosage Strength : 55MG
Packaging : 60
Brand Name : FOQUEST
Approval Date :
Application Number : 2470322
Regulatory Info : Schedule G (CDSA III)
Registration Country : Canada
Regulatory Info : Schedule G (CDSA III)
Registration Country : Canada
Dosage Form : CAPSULE (CONTROLLED RELEASE)
Dosage Strength : 70MG
Packaging : 60
Brand Name : FOQUEST
Approval Date :
Application Number : 2470330
Regulatory Info : Schedule G (CDSA III)
Registration Country : Canada
Regulatory Info : Schedule G (CDSA III)
Registration Country : Canada
Dosage Form : CAPSULE (CONTROLLED RELEASE)
Dosage Strength : 85MG
Packaging : 60
Brand Name : FOQUEST
Approval Date :
Application Number : 2470349
Regulatory Info : Schedule G (CDSA III)
Registration Country : Canada
Regulatory Info : Schedule G (CDSA III)
Registration Country : Canada
Dosage Form : CAPSULE (CONTROLLED RELEASE)
Dosage Strength : 100MG
Packaging : 60
Brand Name : FOQUEST
Approval Date :
Application Number : 2470357
Regulatory Info : Schedule G (CDSA III)
Registration Country : Canada
LOOKING FOR A SUPPLIER?